Somatostatin receptor type 5 — Drug Target

All drugs that target Somatostatin receptor type 5 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Somatostatin Analog [EPC]

Marketed (1)

• Signifor · Recordati · Somatostatin Analog [EPC] · Oncology
  Signifor works by binding to somatostatin receptors on the surface of cells, mimicking the natural hormone somatostatin to reduce cortisol production.